ArsenalBio is a biotechnology company that develops cell therapies for cancer. The company's products include CAR-T and TCR therapies that target solid tumors. ArsenalBio's technology is based on synthetic biology and machine learning algorithms. The company's products are designed to improve patient outcomes and reduce healthcare costs. ArsenalBio serves pharmaceutical and biotechnology companies, hospitals, and clinical laboratories.